CLINICAL_TRIALS
trial_result
· 2016-11-02
Clinical Trial Update: A Study of Single Doses of RO4998452 in Patients With Type 2 Diabetes [Phase 1]
Summary
A Phase 1 study evaluating single doses of RO4998452 in patients with Type 2 diabetes has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Hoffmann-La Roche | Conditions: Diabetes Mellitus Type 2 | Phase 1 | Status: COMPLETED